Filing Details

Accession Number:
0001179110-13-017422
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-04 16:51:31
Reporting Period:
2013-12-02
Filing Date:
2013-12-04
Accepted Time:
2013-12-04 16:51:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Depomed Inc DEPO Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1367754 M Matthew Gosling 7999 Gateway Boulevard, Suite 300
Newark CA 94560
Senior Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-02 5,692 $8.40 11,396 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold for payment of payroll tax withholdings in connection with vesting of restricted stock. The sales reported in this Form 4 were sold pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
  2. Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.